Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Veterinary medicines
Search for medicinal products
Search for packages
ATC tree
Print
NGENLA
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1875911
Name of medicinal product:
NGENLA
Active substances:
Somatrogon
Estonian
,
English
,
Latin
ATC code:
H01AC08
Dosage form:
solution for injection in pre-filled pen
Route of administration:
subcutaneous use
Strengh:
60mg
Amount in package:
1TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.
Safety features:
Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL):
EST
Labelling:
Last imported to Estonia:
September 21, 2023
:
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Patients and healthcare professionals are asked to report any suspected adverse reactions
to State Agency of Medicines
.
State Agency of Medicines
Marketing authorization
Marketing authorization holder:
Pfizer Europe MA EEIG
Marketing authorization number:
EU/1/21/1617
Marketing authorization issued on:
February 14, 2022
Marketing authorization expires on:
February 15, 2027
Marketing authorization procedure type:
Centralised
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Entry/Changing date: March 1, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here